Literature DB >> 24320162

Multiple MAGE-A genes as surveillance marker for the detection of circulating tumor cells in patients with ovarian cancer.

Meixiang Sang1, Xiaohua Wu, Xiaojie Fan, Meijie Sang, Xinliang Zhou, Nan Zhou.   

Abstract

Ovarian cancer is a leading cause of death among gynecologic malignancies. In this study, we reported the expression of melanoma-associated antigens A (MAGE-A) genes in peripheral blood from 80 patients with ovarian cancer and 30 healthy donors. MAGE-As expression was associated with the factors indicating poor prognosis. The expressions of MAGE-As and each individual MAGE-A genes were also associated with low overall survival of patients with ovarian cancer. Our results suggested MAGE-A genes may have the potential to be surveillance markers for the detection of circulating tumor cells and represent a poor prognosis for patients with ovarian cancer.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24320162     DOI： 10.3109/1354750X.2013.865275

Source DB:  PubMed          Journal:  Biomarkers        ISSN： 1354-750X            Impact factor:   2.658


  14 in total

1.  Detection of Circulating Gastrointestinal Cancer Cells in Conditionally Reprogrammed Cell Culture.

Authors:  Chun-Seok Yang; In-Hwan Kim; Hyun-Dong Chae; Dae-Dong Kim; Chang-Ho Jeon
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

Review 2.  The expression of cancer-testis antigen in ovarian cancer and the development of immunotherapy.

Authors:  Jianhang Zhao; Zhaoxu Xu; Yan Liu; Xiaobin Wang; Xinli Liu; Yanan Gao; Ying Jin
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 3.  A meta-analysis of the prognostic value of circulating tumor cells in ovarian cancer.

Authors:  Xiaodan He; Shenjie Li; Yali Ni; Ming Jin; Xin Fu
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

4.  Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics.

Authors:  Tongxia Wang; Yan Gao; Xi Wang; Junrui Tian; Yuan Li; Bo Yu; Cuiyu Huang; Hui Li; Huamao Liang; David M Irwin; Huanran Tan; Hongyan Guo
Journal:  Chin J Cancer Res       Date:  2022-04-30       Impact factor: 4.026

Review 5.  Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer.

Authors:  Maria Luisa Gasparri; Delia Savone; Raad Aris Besharat; Ammad Ahmad Farooqi; Filippo Bellati; Ilary Ruscito; Pierluigi Benedetti Panici; Andrea Papadia
Journal:  Tumour Biol       Date:  2015-10-26

6.  Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis.

Authors:  Long Cui; Joseph Kwong; Chi Chiu Wang
Journal:  J Ovarian Res       Date:  2015-06-16       Impact factor: 4.234

7.  Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.

Authors:  Yunlan Zhou; Bingxian Bian; Xiangliang Yuan; Guohua Xie; Yanhui Ma; Lisong Shen
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 8.  Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.

Authors:  Xianliang Cheng; Lei Zhang; Yajuan Chen; Chen Qing
Journal:  J Ovarian Res       Date:  2017-11-13       Impact factor: 4.234

9.  MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer.

Authors:  Lina Gu; Meixiang Sang; Danjing Yin; Fei Liu; Yunyan Wu; Shina Liu; Weina Huang; Baoen Shan
Journal:  Thorac Cancer       Date:  2018-02-12       Impact factor: 3.500

10.  Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report.

Authors:  Hui Fan; Xuechun Lu; Xiaohui Wang; Yang Liu; Bo Guo; Yan Zhang; Wenying Zhang; Jing Nie; Kaichao Feng; Meixia Chen; Yajing Zhang; Yao Wang; Fengxia Shi; Xiaobing Fu; Hongli Zhu; Weidong Han
Journal:  J Immunol Res       Date:  2014-05-21       Impact factor: 4.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.